SEARCH

SEARCH BY CITATION

References

  • 1
    Regitz-Zagrosek V, Lundqvist CB, Borghi C, Cifkova R, Ferreira R, Foidart JM, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J 2011;32:314797.
  • 2
    Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:23068.
  • 3
    Soma-Pillay P, Nene Z, Mathivha T, Macdonald A. The effect of warfarin dosage on maternal and fetal outcomes in pregnant women with prosthetic heart valves. Obstetric Medicine 2011;4:247.
  • 4
    Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: american College of Chest Physicians Evidence-Based Clinical Practice Guidelines(8th Edition) . Chest 2008;6(suppl):84486.
  • 5
    Quinn J, Brooks R, Peebles D, Walker F, Cohen H. Dose-escalated low molecular weight heparin provides effective anticoagulation for women with mechanical heart valves during pregnancy: a single-centre experience. Haematologica 2009;94:160812.
  • 6
    Suri V, Keepanasseril A, Aggarwal N, Chopra S, Bagga R, Sikka P, et al. Mechanical valve prosthesis and anticoagulation regimens in pregnancy: a tertiary centre experience. Eur J Obstet Gynecol Reprod Biol 2011;159:3203.
  • 7
    McLintock C, McCowan L, North RA. Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin. BJOG: An International Journal of Obstetrics & Gynaecology 2009;116:158592.
  • 8
    Barbour LA, Oja JL, Schultz LK. A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation. Am J Obstet Gynecol 2004;191:10249.
  • 9
    Fareed J, Jeske W, Hoppensteadt D, Clarizio R, Walenga JM. Low-molecular-weight heparins: pharmacologic profile and product differentiation. Am J Cardiol 1998;82:3L10L.
  • 10
    Elkayam U, Singh H, Irani A, Akhter MW. Anticoagulation in pregnant women with prosthetic heart valves. Journal of cardiovascular pharmacology and therapeutics 2004;9:10715.